Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zimmer pays $13.35bn in cash and stock for Biomet

Executive Summary

Positioning itself to become a top competitor in the $45bn musculoskeletal market, Zimmer Holdings Inc. bought public orthopedic device maker Biomet Inc. for $13.35bn--$10.35bn in cash and $3bn in Zimmer stock. Zimmer plans to refinance some of its own debt, including an existing $250mm in notes due 2014, in addition to certain Biomet debt.

Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies